TRCT
GEHC icon

Tower Research Capital (TRC)’s GE HealthCare GEHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528K Sell
8,253
-31,171
-79% -$2.05M 0.01% 987
2026
Q1 		$2.81M Buy
39,424
+9,445
+32% +$745K 0.07% 269
2025
Q4 		$2.46M Buy
29,979
+19,892
+197% +$1.55M 0.06% 284
2025
Q3 		$758K Sell
10,087
-5,711
-36% -$426K 0.02% 626
2025
Q2 		$1.17M Buy
15,798
+6,207
+65% +$432K 0.03% 485
2025
Q1 		$774K Sell
9,591
-28,545
-75% -$2.45M 0.02% 611
2024
Q4 		$2.98M Buy
38,136
+19,467
+104% +$1.65M 0.06% 258
2024
Q3 		$1.75M Sell
18,669
-72,266
-79% -$6.07M 0.05% 323
2024
Q2 		$7.09M Buy
90,935
+61,042
+204% +$4.98M 0.12% 140
2024
Q1 		$2.72M Sell
29,893
-36,867
-55% -$3.07M 0.07% 215
2023
Q4 		$5.16M Buy
66,760
+41,269
+162% +$2.89M 0.06% 250
2023
Q3 		$1.73M Buy
25,491
+11,331
+80% +$824K 0.05% 352
2023
Q2 		$1.15M Buy
14,160
+7,505
+113% +$599K 0.04% 428
2023
Q1 		$546K Buy
+6,655
New +$475K 0.02% 774

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Tower Research Capital (TRC)'s GEHC Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its GE HealthCare (GEHC) stake by 79% in Q2 2026, selling an estimated $2.05M and leaving 8,253 shares worth $528K. The position accounts for 0.01% of the portfolio, ranked #987.

Tower Research Capital (TRC) first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.09M in Q2 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Tower Research Capital (TRC) held 8,253 shares of GE HealthCare worth $528K as of Q2 2026.
  • Tower Research Capital (TRC) sold 31,171 GE HealthCare shares in Q2 2026, an estimated $2.05M.
  • GE HealthCare made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #987 holding.
  • Tower Research Capital (TRC) first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s GE HealthCare position peaked at $7.09M in Q2 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.